Journal of Emergencies, Trauma, and Shock
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
Users online:2236   Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size   

 Table of Contents    
Year : 2022  |  Volume : 15  |  Issue : 2  |  Page : 112-113
Myocardial infarction after ChAdOx1 nCoV-19 in a young male

Department of General Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India

Click here for correspondence address and email

Date of Submission28-Feb-2022
Date of Acceptance08-Mar-2022
Date of Web Publication27-Jun-2022

How to cite this article:
Sagar V V, Wanjari A, Kumar S, Acharya S. Myocardial infarction after ChAdOx1 nCoV-19 in a young male. J Emerg Trauma Shock 2022;15:112-3

How to cite this URL:
Sagar V V, Wanjari A, Kumar S, Acharya S. Myocardial infarction after ChAdOx1 nCoV-19 in a young male. J Emerg Trauma Shock [serial online] 2022 [cited 2022 Aug 11];15:112-3. Available from:


Myocardial infarction rarely happens in young age.[1] Hereby, we report the case of a 21-year-old patient who presented with myocardial infarction 14 days after receiving the ChAdOx1 nCoV-19 COVID-19 (AstraZeneca/Vaxzevria) vaccine. Sometimes thrombotic events associated with thrombocytopenia after immunisation occurs known as vaccine-induced immune thrombotic thrombocytopenia (VITT) which manifests 3–30 days post vaccination. Thrombocytopenia, raised Platelet factor-4 antibodies, increased d-dimer, thrombi are common findings in VITT.[2],[3] Possible etiological factors such as hyperhomocystenemia, vegetation, autoimmune, nephrotic syndrome, obesity, metabolic syndrome, stress, hypercoagulability, comorbidities were evaluated and excluded.[4]

The presentation here is chest pain radiating to arms and vomiting for 5 days. He received vaccination 14 days prior to symptoms. The patient has no history of smoking, alcohol, and substance abuse. Electrocardiogram showing ST elevation Anterior wall Myocardial infarction [Figure 1]a. Echocardiography showed akinetic anterior and lateral wall, left ventricular apical thrombus, severe left ventricular dysfunction, regional wall motion abnormality present, dilated left atrium, left ventricle, left ventricular ejection fraction-35%, grade 1 diastolic dysfunction. Biochemical parameters reveal elevated cardiac markers troponin I 96000 pg/ml, antinuclear antibody-0.11, homocysteine 14.5micromol/l, HbA1C-5%. Patient was treated with anticoagulants, dual antiplatelets, statins, beta blockers, ACE inhibitors, antianginals and diuretics. Coronary angiography revealed occluded mid left anterior descending artery and proximal diagonal artery [Figure 1]b. Later reperfusion was achieved through percutaneous transluminal coronary angioplasty by placing three stents.
Figure 1: (a) ECG suggestive of ST elevation in lead 1, aVL, V1-V6, pathological q-waves in V1-V6, poor R-wave progression, QRS > 0.12 s in V1, V2, tall R-wave in V1, wide S-wave in L1, V5, V6, suggestive of acute anterior wall and (b) coronary angiography

Click here to view

It is the onus of responsibility for dispelling erroneous or exaggerated reports of COVID-19 vaccination dangers. Further research study could be vital. It is commonly acknowledged that vaccination benefits outweigh the risks and must be mindful to link negative outcomes to vaccine, anticipate patient queries and findings should not be overstated.

Declaration of patient consent

We certify that we have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal his identity, but anonymity cannot be guaranteed.

Research quality and ethics statement

We followed applicable EQUATOR Network (http://www. equator-network. org/) guidelines, notably the CARE guideline, during the conduct of this report.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Egred M, Viswanathan G, Davis GK. Myocardial infarction in young adults. Postgrad Med J 2005;81:741-5.  Back to cited text no. 1
Kumar S, Diwan SK, Dubey S. Myocardial infarction in organophosphorus poisoning: Association or just chance? J Emerg Trauma Shock 2014;7:131-2.  Back to cited text no. 2
[PUBMED]  [Full text]  
Flower L, Bares Z, Santiapillai G, Harris S. Acute ST-segment elevation myocardial infarction secondary to Vaccine-Induced Immune Thrombosis with Thrombocytopaenia (VITT). BMJ Case Rep 2021;14:e245218.  Back to cited text no. 3
Jagtap G, Talwar D, Kumar S, Acharya S, Ansari I, Rajput M. Type 2 myocardial infarction in COVID19: World's first case series. Med Sci 2021;25:1583-8.  Back to cited text no. 4

Correspondence Address:
V V. S. S. Sagar
Department of General Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jets.jets_20_22

Rights and Permissions


  [Figure 1]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  

    Article Figures

 Article Access Statistics
    PDF Downloaded29    
    Comments [Add]    

Recommend this journal